The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Cost-effectiveness of adjuvant chemotherapy in early stage breast cancer.

Preethi  John

No Relationships to Disclose

Raveendhara R  Bannuru

No Relationships to Disclose

Joshua T.  Cohen

Consulting or Advisory Role - Axovant Sciences; Johnson & Johnson; Lundbeck; Novartis; Partnership for Health Analytic Research; Precision Health Economics; Takeda; Veritech Corporation

Research Funding - Amgen; Biogen; GE Healthcare; Genentech; Gilead Sciences; Janssen; Merck; National Pharmaceutical Council; Novartis; Otsuka; Pfizer; Pharma+; Purdue Pharma; Sanofi; Vertex

Rachel J.  Buchsbaum

Patents, Royalties, Other Intellectual Property - “Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis” Provisional patent application: Docket Number: MITX-9505/00US 317239-2690 5/13/2017 application in collaboration with Dr. Mohammad Movassaghi (Inst)

John Kalil  Erban

Stock and Other Ownership Interests  - Express Scripts; Merck

Consulting or Advisory Role - Tesaro